Release 5.9.0: Saved Query Alerts, Query Details, Collection Sizes and more!

Saved Query Alerts.

Receive a notification email when new data is added for your saved queries.

Query Details Improvements.

View details of your joined query when navigating between cited/citing panes.

Collection Limit Increase.

Create collections of up to 50,000 Patents or Scholarly Works.

Use Of Cannabinoids In The Treatment Of Epilepsy

  • Published: Dec 17, 2015
  • Family: 35
  • Cited Works: 0
  • Cited by: 3
  • Cites: 0
  • Additional Info: Full text
Abstract

The present disclosure relates to the use of cannabidiol (CBD) for the reduction of total convulsive seizure frequency in the treatment of “treatment-resistant epilepsy” (TRE). In particular, the disclosure relates to the use of CBD of treating TRE when the TRE is Dravet syndrome; myoclonic absence seizures or febrile infection related epilepsy syndrome (FIRES). The disclosure further relates to the use of CBD in combination with one or more anti-epileptic drugs (AEDs).


Claims
Owners (US)
CPC Classifications
Download PDF
Document Preview
Document History
  • Publication: Dec 17, 2015
  • Application: Jun 17, 2015
    US US 201514741783 A
  • Priority: Apr 17, 2015
    GB GB 201506550 A
  • Priority: Jun 17, 2014
    GB GB 201410771 A

Sign in to the Lens